VentriPoint Diagnostics Ltd. (VPTDF) Receives Expanded License from Health Canada
Today, VentriPoint Diagnostics reported receiving an expanded license from Health Canada that allows the company to sell the VMS™ heart analysis system for clinical use in Canada. The expansion was for the NRV™ application for the analysis of 2-D ultrasound images for patients with non-specific heart disease. The NRV™ application will enable healthcare providers to rapidly and accurately assess the status of the right ventricle in all patients that do not have significant congenital heart defects or pulmonary hypertension, yet may have a variety of other conditions. VentriPoint’s VMS-2DE™ heart analysis system will be used in conjunction with the NRV™…